The Phase III `High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
Study Number: GU013
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
RT Credentialing Pending
- Navigator Carrie, 309-243-3621 firstname.lastname@example.org
- Drea, 309-243-3626 email@example.com